ICU Medical (NASDAQ:ICUI) reported second-quarter revenue of $548 million, up 6% organically and 1% on a reported basis, as growth in its consumables and infusion systems businesses helped offset continued pressure in Vital Care and the effects of the IV Solutions joint venture deconsolidation.
Adj
Medical device company ICU Medical (NASDAQ:ICUI) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 1.5% year on year to $5...
Medical device company ICU Medical (NASDAQ:ICUI) will be reporting earnings this Thursday after market close. Here’s what you need to know. ICU Medical beat ...
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cord...
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorab...
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only reali...
ICU Medical has been treading water for the past six months, recording a small loss of 3.3% while holding steady at $142.98. The stock also fell short of the...
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a...
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th...
ICU Medical’s first quarter results in 2026 were marked by outperformance against Wall Street expectations, with revenue and non-GAAP earnings per share both...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Medical device company ICU Medical (NASDAQ:ICUI) reported Q1 CY2026 results exceeding the market’s revenue expectations, but sales fell by 12.3% year on year...
Medical device company ICU Medical (NASDAQ:ICUI) beat Wall Street’s revenue expectations in Q1 CY2026, but sales fell by 11.6% year on year to $530.2 million...
Medical device company ICU Medical (NASDAQ:ICUI) will be reporting results this Thursday after the bell. Here’s what you need to know. ICU Medical beat analy...
ICU Medical has been treading water for the past six months, recording a small return of 2.8% while holding steady at $120.94. Is now the time to buy ICU Med...
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at ICU Medical (NASDAQ:ICUI) and...
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest ...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...
A number of stocks fell in the afternoon session after the February jobs report revealed an unexpected contraction in employment, with the healthcare industry showing significant job losses.
